Perrine Roux

Summary

Country: France

Publications

  1. ncbi request reprint Predictors of non-adherence to methadone maintenance treatment in opioid-dependent individuals: implications for clinicians
    Perrine Roux
    INSERM U912 ORS PACA, 23 rue Stanislas Torrents, 13006 Marseille, France
    Curr Pharm Des 20:4097-105. 2014
  2. ncbi request reprint Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort
    Perrine Roux
    INSERM UMR912 SESSTIM, Marseille, France
    Antivir Ther 19:171-8. 2014
  3. pmc Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone
    Perrine Roux
    Division on Substance Abuse, New York State Psychiatric Institute, Department of Psychiatry, and College of Physicians and Surgeons, Columbia University, 1051 Riverside Dr, Unit 120, New York, NY 10032, USA
    Pain 154:1442-8. 2013
  4. pmc Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial
    Perrine Roux
    INSERM U912 SESSTIM, Marseille, France
    BMC Public Health 12:488. 2012
  5. pmc Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France)
    Dominique Salmon-Ceron
    Unité de maladies infectieuses, Pôle Médecine, Hopital Cochin, Paris, France
    BMC Health Serv Res 12:59. 2012
  6. pmc Non-medical use of opioids among HIV-infected opioid dependent individuals on opioid maintenance treatment: the need for a more comprehensive approach
    Perrine Roux
    INSERM, U912 SE4S, 23 rue Stanislas Torrents, 13006 Marseille, France
    Harm Reduct J 8:31. 2011
  7. doi request reprint Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician
    P Roux
    INSERM, U912 SE4S, Marseille, France
    Drug Alcohol Depend 116:228-32. 2011
  8. ncbi request reprint Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment
    Perrine Roux
    Institut National de la Sante et de la Recherche Medicale, U912 SE4S, Marseille, France
    Clin Infect Dis 49:1433-40. 2009
  9. doi request reprint Reducing harm from injecting pharmaceutical tablet or capsule material by injecting drug users
    Perrine Roux
    INSERM, U912 SE4S, Marseille, France
    Drug Alcohol Rev 30:287-90. 2011
  10. doi request reprint Determinants of benzodiazepine use in a representative population of HIV-infected individuals: the role of HIV status disclosure (ANRS-EN12-VESPA study)
    Perrine Roux
    INSERM, U, Marseille, France
    AIDS Care 23:1163-70. 2011

Detail Information

Publications28

  1. ncbi request reprint Predictors of non-adherence to methadone maintenance treatment in opioid-dependent individuals: implications for clinicians
    Perrine Roux
    INSERM U912 ORS PACA, 23 rue Stanislas Torrents, 13006 Marseille, France
    Curr Pharm Des 20:4097-105. 2014
    ..With data from the Methaville trial we investigated the evolution of non-adherence to methadone and the effect of pre-treatment and in-treatment factors on longterm non-adherence to methadone...
  2. ncbi request reprint Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort
    Perrine Roux
    INSERM UMR912 SESSTIM, Marseille, France
    Antivir Ther 19:171-8. 2014
    ..We used longitudinal data to assess factors associated with non-adherence to HAART...
  3. pmc Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone
    Perrine Roux
    Division on Substance Abuse, New York State Psychiatric Institute, Department of Psychiatry, and College of Physicians and Surgeons, Columbia University, 1051 Riverside Dr, Unit 120, New York, NY 10032, USA
    Pain 154:1442-8. 2013
    ..These data suggest that Bup/Nx was effective in reducing pain and supplemental oxycodone use. Importantly, adequate management of pain and withdrawal symptoms by Bup/Nx may reduce oxycodone preference in this population...
  4. pmc Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial
    Perrine Roux
    INSERM U912 SESSTIM, Marseille, France
    BMC Public Health 12:488. 2012
    ..This study aims to assess the effectiveness of methadone in patients who initiated treatment in primary care compared with those who initiated it in a CSAPA, by measuring abstinence from street opioid use after one year of treatment...
  5. pmc Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France)
    Dominique Salmon-Ceron
    Unité de maladies infectieuses, Pôle Médecine, Hopital Cochin, Paris, France
    BMC Health Serv Res 12:59. 2012
    ..Treatment for the hepatitis C virus (HCV) may be delayed significantly in HIV/HCV co-infected patients. Our study aims at identifying the correlates of access to HCV treatment in this population...
  6. pmc Non-medical use of opioids among HIV-infected opioid dependent individuals on opioid maintenance treatment: the need for a more comprehensive approach
    Perrine Roux
    INSERM, U912 SE4S, 23 rue Stanislas Torrents, 13006 Marseille, France
    Harm Reduct J 8:31. 2011
    ..abstract:..
  7. doi request reprint Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician
    P Roux
    INSERM, U912 SE4S, Marseille, France
    Drug Alcohol Depend 116:228-32. 2011
    ....
  8. ncbi request reprint Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment
    Perrine Roux
    Institut National de la Sante et de la Recherche Medicale, U912 SE4S, Marseille, France
    Clin Infect Dis 49:1433-40. 2009
    ..We selected a total of 113 patients, accounting for a total of 562 visits for all the analyses...
  9. doi request reprint Reducing harm from injecting pharmaceutical tablet or capsule material by injecting drug users
    Perrine Roux
    INSERM, U912 SE4S, Marseille, France
    Drug Alcohol Rev 30:287-90. 2011
    ..To reduce the harmful consequences of injecting such solutions, drug users have been encouraged to use filters. This research studied the effectiveness of an injection drug user syringe filter (IDUSF) in eliminating these particles...
  10. doi request reprint Determinants of benzodiazepine use in a representative population of HIV-infected individuals: the role of HIV status disclosure (ANRS-EN12-VESPA study)
    Perrine Roux
    INSERM, U, Marseille, France
    AIDS Care 23:1163-70. 2011
    ..They also highlight the need for appropriate case management and psychiatric care to help patients manage the consequences of disclosure...
  11. doi request reprint Adherence to antiretroviral treatment in HIV-positive patients in the Cameroon context: promoting the use of medication reminder methods
    Perrine Roux
    INSERM, U912, SE4S, Marseille, Bouches du rhone, France
    J Acquir Immune Defic Syndr 57:S40-3. 2011
    ..Antiretroviral treatment (ART) scale-up in sub-Saharan Africa has made it possible to investigate the maintenance of adherence to HIV medications. We describe here adherence to ART and identify its correlates in the Cameroonian context...
  12. doi request reprint Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users
    Perrine Roux
    INSERM, U912, SE4S, Marseille, France
    Addiction 107:152-9. 2012
    ..Longitudinal data were used to investigate the relationship between initiating HCV treatment and adherence to ART in HIV/HCV coinfected patients...
  13. doi request reprint The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study
    Perrine Roux
    INSERM U912 SE4S, Marseille, France
    Addiction 103:1828-36. 2008
    ..This study was conducted in order to evaluate whether receiving take-home methadone and buprenorphine may ensure better adherence to HAART in individuals infected with human immunodeficiency virus (HIV) through injection drug use (IDU)...
  14. doi request reprint Self-reported side effects in buprenorphine and methadone patients receiving antiretroviral therapy: results from the MANIF 2000 cohort study
    M Patrizia Carrieri
    NSERM, U912 SE4S, Marseille, France Université Aix Marseille, IRD, UMR S912, Marseille, France
    Addiction 105:2160-8. 2010
    ..The aim of the study was to investigate the relationship between methadone and buprenorphine treatment and self-reported symptoms in HIV-infected opioid dependent individuals receiving antiretroviral therapy (ART)...
  15. doi request reprint Buprenorphine in primary care: risk factors for treatment injection and implications for clinical management
    Perrine Roux
    INSERM, U912 Economic and Social Sciences, Health Systems and Societies, Marseille, France
    Drug Alcohol Depend 97:105-13. 2008
    ..The aim of this study was to identify which factors are predictive of buprenorphine injection in patients receiving office-based buprenorphine...
  16. ncbi request reprint Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: Results from the ANRS CO13 HEPAVIH cohort study
    M Patrizia Carrieri
    INSERM, U912 SESSTIM, Marseille, France Aix Marseille Univ, IRD, UMR S912, Marseille, France ORS PACA, Observatoire Régional de la Santé Provence Alpes Côte d Azur, Marseille, France Electronic address
    J Hepatol 60:46-53. 2014
    ....
  17. ncbi request reprint Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort
    Fabienne Marcellin
    INSERM, UMR912 SESSTIM, 13006, Marseille, France
    Expert Rev Gastroenterol Hepatol 8:351-8. 2014
    ..This article documents the main lessons learned to date from the HEPAVIH data and published literature, while describing research prospects and needs requiring further investigation in the field of patient-reported outcomes. ..
  18. doi request reprint Self-reported alcohol abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort)
    Fabienne Marcellin
    INSERM, UMR912 SESSTIM, Marseille, France
    Addiction 108:1250-8. 2013
    ..Studying alcohol abuse impact, as measured by physicians' perceptions and patients' self-reports, on HIV virological rebound among patients chronically co-infected with HIV and hepatitis C virus (HCV)...
  19. pmc Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in New York City: the need to expand access to buprenorphine/naloxone in marginalized populations
    Sharon Stancliff
    Harm Reduction Coalition, New York, New York 10025, USA
    J Addict Dis 31:278-87. 2012
    ..This pilot study demonstrated that BUP/NX could be successfully used to treat marginalized heroin users...
  20. doi request reprint Predictors of non-prescribed opioid use after one year of methadone treatment: an attributable-risk approach (ANRS-Methaville trial)
    Caroline Lions
    INSERM, UMR912 Economics and Social Sciences Applied to Health and Analysis of Medical Information SESSTIM, 13006 Marseille, France Aix Marseille University, UMR_S912, IRD, 13006 Marseille, France ORS PACA, Southeastern Health Regional Observatory, 13006 Marseille, France Electronic address
    Drug Alcohol Depend 135:1-8. 2014
    ..However many patients continue to use other opioids while on methadone treatment. Studies assessing avoidable cases of continued non-prescribed opioid use during methadone treatment are sparse...
  21. pmc Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers
    Sandra D Comer
    Department of Psychiatry, Division on Substance Abuse, New York State Psychiatric Institute, and College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Neuropsychopharmacology 38:2427-38. 2013
    ..Future studies should continue to evaluate NTX as a potential anti-craving medication for COC dependence. ..
  22. pmc Impact of in-patient research participation on subsequent heroin use patterns: implications for ethics and public health
    Perrine Roux
    Substance Use Research Center, NYSPI, Columbia University, New York, NY 10032, USA
    Addiction 107:642-9. 2012
    ..The primary objective of this study was to assess whether participation in such research alters the frequency of heroin use by non-treatment-seeking opioid-dependent volunteers after study completion...
  23. ncbi request reprint Buprenorphine sniffing as a response to inadequate care in substituted patients: results from the Subazur survey in south-eastern France
    Perrine Roux
    INSERM, U912 SE4S, Marseille, France
    Addict Behav 33:1625-9. 2008
    ..The Subazur survey gave us the opportunity to identify factors associated with buprenorphine sniffing in patients receiving buprenorphine in primary care...
  24. doi request reprint Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data
    Camelia Protopopescu
    INSERM, U912 SE4S, 13006 Marseille, France
    J Antimicrob Chemother 64:599-606. 2009
    ..The aim of this study was to identify factors associated with non-adherence over a 10 year follow-up of the APROCO-COPILOTE cohort during the maintenance phase of highly active antiretroviral therapy (HAART)...
  25. doi request reprint Assessing adherence to antiretroviral therapy in randomized HIV clinical trials: a review of currently used methods
    Fabienne Marcellin
    INSERM, UMR912 SESSTIM, 13006, Marseille, France
    Expert Rev Anti Infect Ther 11:239-50. 2013
    ..The scope of this article is to review and discuss the range of adherence measures currently used in RCTs conducted among HIV-infected adults...
  26. doi request reprint Correlates of poor perceived health among individuals living with HIV and HBV chronic infections: a longitudinal assessment
    Fabienne Marcellin
    INSERM, U912 SE4S, Marseille, France
    AIDS Care 23:501-7. 2011
    ..Individuals with wild-type HBV and multiple hepatitis infection require better clinical management. Further research is needed for hepatitis D virus infection, for which treatment options are currently very limited...
  27. doi request reprint Non-adherence to aspirin in patients undergoing coronary stenting: negative impact of comorbid conditions and implications for clinical management
    Thomas Cuisset
    Department of Cardiology, CHU Timone, Marseille, France
    Arch Cardiovasc Dis 104:306-12. 2011
    ..Premature discontinuation of and reduced adherence to antiplatelet therapy have been identified as major risk factors for stent thrombosis and poor prognosis after acute coronary syndrome...
  28. pmc Brief overdose education can significantly increase accurate recognition of opioid overdose among heroin users
    Jermaine D Jones
    Division on Substance Abuse, New York State Psychiatric Institute, Columbia University, College of Physicians and Surgeons, 1051 Riverside Drive, New York, NY 10032, United States Electronic address
    Int J Drug Policy 25:166-70. 2014
    ..The current study sought to assess the ability of NYSDOH training to increase accurate identification of opioid and non-opioid overdose, and naloxone use among heroin users...